Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Phase I results with rhIL-4 receptor

Feb. 24, 1997

Gene vaccination shows potential against allergy

Feb. 24, 1997

Correlation between asthma and IL-10

Feb. 24, 1997

Method of treating allergies and HIV offered for licensing

Feb. 24, 1997

NIH seeks licensees for method of treating allergies and HIV

Feb. 24, 1997

Antisense compound for asthma shows promise

Feb. 21, 1997

Efficacy of leukotriene antagonist in asthma

Feb. 19, 1997

Pfizer claims 5-LO inhibitors

Feb. 13, 1997

Positive phase II results reported for LiquiVent

Feb. 12, 1997

Dual PDE IV/TNF inhibitors from Pfizer

Feb. 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...